| Message: | Bremelanotide PT-141 allegedly works by activating melanocortin receptors in the brain, therefore helping increase ones sexual stimulation. PT-141, bremelanotide is experimental and is used for the purpose of sexual arousal. It is a melanocortin based peptide that has shown effectiveness in clinical studies on both male and female rats. Male rats have shown erectile response with doses as low as 1-2 mgs whereas most female rats have shown positive results with higher doses around 2-3 mgs. While the dosage requirements tend to be higher for female rats, the observable results in female rats tend to be stronger.
PT-141 (Bremelanotide) is that the 1st of a replacement category of medicine referred to as melanocortin agonists being developed to treat sexual pathology. The mechanism of action of PT-141 (Bremelanotide) could provide important safety and effectualness edges over presently obtainable product as a result of it acts on the pathway that controls sexual operate while not acting directly on the system. Clinical information indicates that PT-141 (Bremelanotide) could also be effective in treating a broad vary of patients tormented by impotence. The nasal formulation of PT-141 (Bremelanotide) being developed is as convenient as oral treatments, is a lot of patient-friendly than invasive treatments for impotence, like injections and trans-urethral pellets, and seems to lead to a fast onset of action.
|
my account
